Thalassämie-Marktgröße, Aktienanalyse bis 2025-2031
Thalassemia Market Report Analysis
Thalassemia Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Bluebird Bio, Inc.
- Acceleron Pharma, Inc.
- GlaxoSmithKline plc.
- La Jolla Pharmaceutical Company
- Incyte Corporation
- IONIS Pharmaceuticals
- Kiadis Pharma
- Sangamo Bioscience
- Lonza Group Ltd.
Regional Overview
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Market Segmentation
By Behandlungsart
- Bluttransfusionen
- Eisen-Chelat-Therapie
- Folsäurepräparate
- Knochenmarktransplantationen
By Krankheitstyp
- Alpha-Thalassämie
- Beta-Thalassämie
By Endbenutzer
- Krankenhäuser
- Forschungsinstitute
- Diagnoselabore
By Geographie
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
Get Free Sample For